Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13
Blood Cancer Journal, Published online: 13 January 2021; doi:10.1038/s41408-020-00398-9Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13 (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 13, 2021 Category: Hematology Authors: Yan Song Ting Du Arghya Ray Krishan Chauhan Mehmet Samur Nikhil Munshi Dharminder Chauhan Kenneth C. Anderson Source Type: research

Conditional relative survival among patients with follicular lymphoma: a population-based study in the Netherlands
Blood Cancer Journal, Published online: 13 January 2021; doi:10.1038/s41408-020-00399-8Conditional relative survival among patients with follicular lymphoma: a population-based study in the Netherlands (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 13, 2021 Category: Hematology Authors: Manette A. W. Dinnessen Otto Visser Sanne H. Tonino Eduardus F. M. Posthuma Nicole M. A. Blijlevens Marie Jos é Kersten Pieternella J. Lugtenburg Avinash G. Dinmohamed Source Type: research

Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis
Blood Cancer Journal, Published online: 11 January 2021; doi:10.1038/s41408-020-00397-wVenetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 11, 2021 Category: Hematology Authors: Vikram J. Premkumar Suzanne Lentzsch Samuel Pan Divaya Bhutani Joshua Richter Sundar Jagannath Michaela Liedtke Arnaud Jaccard Ashutosh D. Wechalekar Raymond Comenzo Vaishali Sanchorawala Bruno Royer Michael Rosenzweig Jason Valent Stefan Sch önland Rafa Source Type: research

Genetic complexity impacts the clinical outcome of follicular lymphoma patients
Blood Cancer Journal, Published online: 11 January 2021; doi:10.1038/s41408-020-00395-yGenetic complexity impacts the clinical outcome of follicular lymphoma patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 11, 2021 Category: Hematology Authors: Mar ía García-Álvarez Sara Alonso- Álvarez Isabel Prieto-Conde Cristina Jim énez M. Eugenia Sarasquete M. Carmen Chill ón Alejandro Medina Ana Balanzategui Rebeca Maldonado Alicia Ant ón Marta Rodr íguez Oscar Blanco Luis G. D íaz Pilar Tamayo Pe Source Type: research

Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Blood Cancer Journal, Published online: 07 January 2021; doi:10.1038/s41408-020-00390-3Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 7, 2021 Category: Hematology Authors: Marc-Andrea Baertsch Elias K. Mai Thomas Hielscher Uta Bertsch Hans J. Salwender Markus Munder Stephan Fuhrmann Ulrich D ührsen Peter Brossart Kai Neben Jana Schlenzka Christina Kunz Marc S. Raab Jens Hillenga ß Anna Jauch Anja Seckinger Dirk Hose Steff Source Type: research

Gene expression profiling-based risk prediction and profiles of immune infiltration in diffuse large B-cell lymphoma
Blood Cancer Journal, Published online: 07 January 2021; doi:10.1038/s41408-020-00404-0Gene expression profiling-based risk prediction and profiles of immune infiltration in diffuse large B-cell lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 7, 2021 Category: Hematology Authors: Selin Merdan Kritika Subramanian Turgay Ayer Johan Van Weyenbergh Andres Chang Jean L. Koff Christopher Flowers Source Type: research

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
Blood Cancer Journal, Published online: 07 January 2021; doi:10.1038/s41408-020-00403-1Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 7, 2021 Category: Hematology Authors: Sara Harrysson Sandra Eloranta Sara Ekberg Gunilla Enblad Mats Jerkeman Bjorn E. Wahlin Per-Ola Andersson Karin E. Smedby Source Type: research

Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients
Blood Cancer Journal, Published online: 07 January 2021; doi:10.1038/s41408-020-00400-4Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 7, 2021 Category: Hematology Authors: A. S. Rosenberg A. Brunson J. Tuscano B. A. Jonas R. Hoeg T. Wun T. H. M. Keegan Source Type: research

Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis
Blood Cancer Journal, Published online: 07 January 2021; doi:10.1038/s41408-020-00392-1Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 7, 2021 Category: Hematology Authors: Francesca Palandri Giuseppe Alberto Palumbo Elena Maria Elli Nicola Polverelli Giulia Benevolo Bruno Martino Elisabetta Abruzzese Mario Tiribelli Alessia Tieghi Roberto Latagliata Francesco Cavazzini Micaela Bergamaschi Gianni Binotto Monica Crugnola Ales Source Type: research

Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma
Blood Cancer Journal, Published online: 07 January 2021; doi:10.1038/s41408-020-00394-zClinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 7, 2021 Category: Hematology Authors: Alessia Castellino Aung M. Tun Yucai Wang Thomas M. Habermann Rebecca L. King Kay M. Ristow James R. Cerhan David J. Inwards Jonas Paludo Stephen M. Ansell Thomas E. Witzig Grzegorz S. Nowakowski Source Type: research

Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway
Blood Cancer Journal, Published online: 07 January 2021; doi:10.1038/s41408-020-00396-xLoss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 7, 2021 Category: Hematology Authors: Antonella Padella Maria Chiara Fontana Giovanni Marconi Eugenio Fonzi Elisabetta Petracci Anna Ferrari Carmen Baldazzi Cristina Papayannidis Andrea Ghelli Luserna Di Ror á Nicoletta Testoni Gastone Castellani Torsten Haferlach Giovanni Martinelli Giorgia Source Type: research

The use of monocyte subset repartitioning by flow cytometry for diagnosis of chronic myelomonocytic leukaemia
Blood Cancer Journal, Published online: 07 January 2021; doi:10.1038/s41408-020-00401-3The use of monocyte subset repartitioning by flow cytometry for diagnosis of chronic myelomonocytic leukaemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 7, 2021 Category: Hematology Authors: Aarya Murali Donna Cross Peter Mollee Source Type: research

Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma
Blood Cancer Journal, Published online: 14 December 2020; doi:10.1038/s41408-020-00393-0Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 14, 2020 Category: Hematology Authors: Yanyan Gu Benjamin G. Barwick Mala Shanmugam Craig C. Hofmeister Jonathan Kaufman Ajay Nooka Vikas Gupta Madhav Dhodapkar Lawrence H. Boise Sagar Lonial Source Type: research

Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients
Blood Cancer Journal, Published online: 11 December 2020; doi:10.1038/s41408-020-00391-2Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 11, 2020 Category: Hematology Authors: Alissa Visram Abdullah S. Al Saleh Harsh Parmar Jennifer S. McDonald John C. Lieske Iuliana Vaxman Eli Muchtar Miriam Hobbs Amie Fonder Yi L. Hwa Francis K. Buadi David Dingli Martha Q. Lacy Angela Dispenzieri Prashant Kapoor Suzanne R. Hayman Rahma Warsa Source Type: research

Genetic and epigenetic determinants of diffuse large B-cell lymphoma
Blood Cancer Journal, Published online: 04 December 2020; doi:10.1038/s41408-020-00389-wGenetic and epigenetic determinants of diffuse large B-cell lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 4, 2020 Category: Hematology Authors: Tanner J. Bakhshi Philippe T. Georgel Source Type: research

Venetoclax-based chemotherapy in acute and chronic myeloid neoplasms: literature survey and practice points
Blood Cancer Journal, Published online: 23 November 2020; doi:10.1038/s41408-020-00388-xVenetoclax-based chemotherapy in acute and chronic myeloid neoplasms: literature survey and practice points (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 23, 2020 Category: Hematology Authors: Naseema Gangat Ayalew Tefferi Source Type: research

Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia
Blood Cancer Journal, Published online: 20 November 2020; doi:10.1038/s41408-020-00387-yPrognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 20, 2020 Category: Hematology Authors: Prateek Pophali Aasiya Matin Abhishek A. Mangaonkar Ryan Carr Moritz Binder Aref Al-Kali Kebede H. Begna Kaaren K. Reichard Hassan Alkhateeb Mithun V. Shah Ayalew Tefferi William J. Hogan Mark R. Litzow Mrinal M. Patnaik Source Type: research

Functional validation of TERT and TERC variants of uncertain significance in patients with short telomere syndromes
Blood Cancer Journal, Published online: 17 November 2020; doi:10.1038/s41408-020-00386-zFunctional validation of TERT and TERC variants of uncertain significance in patients with short telomere syndromes (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 17, 2020 Category: Hematology Authors: Alejandro Ferrer Abhishek A. Mangaonkar Susanna Stroik Michael T. Zimmermann Ashley N. Sigafoos Patrick S. Kamath Douglas A. Simonetto Mark E. Wylam Eva M. Carmona Konstantinos N. Lazaridis Steve Peters Keith Stewart Eric W. Klee Eric A. Hendrickson Mrina Source Type: research

Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07
Blood Cancer Journal, Published online: 13 November 2020; doi:10.1038/s41408-020-00383-2Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07 (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 13, 2020 Category: Hematology Authors: Renato Bassan Chiara Pavoni Tamara Intermesoli Orietta Spinelli Manuela Tosi Ernesta Audisio Filippo Marmont Chiara Cattaneo Erika Borlenghi Sergio Cortelazzo Irene Cavattoni Monica Fumagalli Daniele Mattei Claudio Romani Agostino Cortelezzi Nicola Fracch Source Type: research

Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities
Blood Cancer Journal, Published online: 10 November 2020; doi:10.1038/s41408-020-00385-0Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 10, 2020 Category: Hematology Authors: Andrew Staron Lawreen H. Connors Luke Zheng Gheorghe Doros Vaishali Sanchorawala Source Type: research

Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features
Blood Cancer Journal, Published online: 09 November 2020; doi:10.1038/s41408-020-00380-5Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 9, 2020 Category: Hematology Authors: Kimon V. Argyropoulos Melissa Pulitzer Francesco Maura Abhinita Mohanty Patrizia Mondello Steven M. Horwitz Patricia Myskowski Alison Moskowitz Ahmet Dogan Christiane Querfeld Franck Rapaport Marina Siakantaris Peter C. Louis Natasha Galasso Marcel R. M. Source Type: research

Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients
Blood Cancer Journal, Published online: 09 November 2020; doi:10.1038/s41408-020-00382-3Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 9, 2020 Category: Hematology Authors: Jordan E. Krull Kerstin Wenzl Keenan T. Hartert Michelle K. Manske Vivekananda Sarangi Matthew J. Maurer Melissa C. Larson Grzegorz S. Nowakowski Stephen M. Ansell Ellen McPhail Thomas M. Habermann Brian K. Link Rebecca L. King James R. Cerhan Anne J. Nov Source Type: research

Hairy cell leukemia expresses programmed death-1
Blood Cancer Journal, Published online: 05 November 2020; doi:10.1038/s41408-020-00384-1Hairy cell leukemia expresses programmed death-1 (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 5, 2020 Category: Hematology Authors: Priyadarshini Kumar Qi Gao Alexander Chan Natasha Lewis Allison Sigler Janine Pichardo Wenbin Xiao Mikhail Roshal Ahmet Dogan Source Type: research

Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management
Blood Cancer Journal, Published online: 04 November 2020; doi:10.1038/s41408-020-00370-7Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 4, 2020 Category: Hematology Authors: Ilaria J. Chicca Jennifer L. J. Heaney Gulnaz Iqbal Janet A. Dunn Stella Bowcock Guy Pratt Kwee L. Yong Timothy D. Planche Alex Richter Mark T. Drayson Source Type: research

EBV-related lymphoma after long-term daratumumab treatment: a case report
Blood Cancer Journal, Published online: 04 November 2020; doi:10.1038/s41408-020-00379-yEBV-related lymphoma after long-term daratumumab treatment: a case report (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 4, 2020 Category: Hematology Authors: Ilse P. G. Verpoorte-Botden Monique C. Minnema Reinier A. P. Raymakers Source Type: research

Correction: Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients
Blood Cancer Journal, Published online: 04 November 2020; doi:10.1038/s41408-020-00374-3Correction: Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 4, 2020 Category: Hematology Authors: S. Thiant M. M. Moutuou P. Laflamme R. Sidi Boumedine D. M. Leboeuf L. Busque J. Roy M. Guimond Source Type: research

Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX
Blood Cancer Journal, Published online: 03 November 2020; doi:10.1038/s41408-020-00375-2Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 3, 2020 Category: Hematology Authors: Jonathan L. Kaufman Meletios A. Dimopoulos Darrell White Lotfi Benboubker Gordon Cook Merav Leiba James Morton P. Joy Ho Kihyun Kim Naoki Takezako Philippe Moreau Heather J. Sutherland Hila Magen Shinsuke Iida Jin Seok Kim H. Miles Prince Tara Cochrane Al Source Type: research

Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients
Blood Cancer Journal, Published online: 03 November 2020; doi:10.1038/s41408-020-00381-4Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 3, 2020 Category: Hematology Authors: Despina Fotiou Maria Roussou Charikleia Gakiopoulou Erasmia Psimenou Maria Gavriatopoulou Magdalini Migkou Nikolaos Kanellias Ioanna Dialoupi Evangelos Eleutherakis-Papaiakovou Stavroula Giannouli Christina Delavinia Kostantinos Efstathiou Sofoklis Kontog Source Type: research

VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo
Blood Cancer Journal, Published online: 02 November 2020; doi:10.1038/s41408-020-00378-zVIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 2, 2020 Category: Hematology Authors: Tengteng Yu Bharat Chaganty Liang Lin Lijie Xing Boopathy Ramakrishnan Kenneth Wen Phillip A. Hsieh Andrew Wollacott Karthik Viswanathan Hedy Adari Shih-Feng Cho Yuyin Li Hailin Chen Wenjuan Yang Yan Xu Gang An Lugui Qiu Nikhil Munshi Gregory Babcock Zach Source Type: research

New directions for emerging therapies in acute myeloid leukemia: the next chapter
Blood Cancer Journal, Published online: 30 October 2020; doi:10.1038/s41408-020-00376-1New directions for emerging therapies in acute myeloid leukemia: the next chapter (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 30, 2020 Category: Hematology Authors: Naval Daver Andrew H. Wei Daniel A. Pollyea Amir T. Fathi Paresh Vyas Courtney D. DiNardo Source Type: research

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
Blood Cancer Journal, Published online: 30 October 2020; doi:10.1038/s41408-020-00377-0Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 30, 2020 Category: Hematology Authors: Alejandro Medina Noemi Puig Juan Flores-Montero Cristina Jimenez M.-Eugenia Sarasquete Mar ía Garcia-Alvarez Isabel Prieto-Conde Carmen Chillon Miguel Alcoceba Norma C. Gutierrez Albert Oriol Laura Rosinol Joan Blad è Mercedes Gironella Miguel T. Hernan Source Type: research

Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study
Blood Cancer Journal, Published online: 23 October 2020; doi:10.1038/s41408-020-00369-0Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 23, 2020 Category: Hematology Authors: Paul G. Richardson Hans C. Lee Al-Ola Abdallah Adam D. Cohen Prashant Kapoor Peter M. Voorhees Axel Hoos Karrie Wang January Baron Trisha Piontek Julie Byrne Scott Richmond Roxanne C. Jewell Joanna Opalinska Ira Gupta Sagar Lonial Source Type: research

A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
Blood Cancer Journal, Published online: 19 October 2020; doi:10.1038/s41408-020-00371-6A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 19, 2020 Category: Hematology Authors: Yiyun Wang Yingying Yang Ruimin Hong Houli Zhao Guoqing Wei Wenjun Wu Huijun Xu Jiazhen Cui Yanlei Zhang Alex H. Chang Yongxian Hu He Huang Source Type: research

Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults
Blood Cancer Journal, Published online: 19 October 2020; doi:10.1038/s41408-020-00373-4Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 19, 2020 Category: Hematology Authors: Sze P. Tsui Ho W. Ip Nicole Y. Saw Chunxiao Zhang Arthur K. Cheung Nelson K. Ng Cheuk H. Man Stephen S. Lam Wing F. Tang Chi H. Lin Grace H. Cheng Chun H. Au Edmond S. Ma Tsun L. Chan Jason C. So Margaret H. Ng Kelvin C. Cheng Kit F. Wong Lai P. Siu Sze F Source Type: research

Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality
Blood Cancer Journal, Published online: 19 October 2020; doi:10.1038/s41408-020-00372-5Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 19, 2020 Category: Hematology Authors: Joaqu ín Martínez-López Mar ía-Victoria Mateos Cristina Encinas Anna Sureda Jos é Ángel Hernández-Rivas Ana Lopez de la Gu ía Diego Conde Isabel Krsnik Elena Prieto Rosal ía Riaza Grau Mercedes Gironella Mar ía Jesús Blanchard Nerea Caminos Car Source Type: research

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
Blood Cancer Journal, Published online: 16 October 2020; doi:10.1038/s41408-020-00366-3International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM) (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 16, 2020 Category: Hematology Authors: Mar ía-Victoria Mateos Shaji Kumar Meletios A. Dimopoulos Ver ónica González-Calle Efstathios Kastritis Roman Hajek Carlos Fern ández De Larrea Gareth J. Morgan Giampaolo Merlini Hartmut Goldschmidt Catarina Geraldes Alessandro Gozzetti Charalampia Ky Source Type: research

An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics
Blood Cancer Journal, Published online: 14 October 2020; doi:10.1038/s41408-020-00367-2An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 14, 2020 Category: Hematology Authors: Phuc H. Hoang Alex J. Cornish Amy L. Sherborne Daniel Chubb Scott Kimber Graham Jackson Gareth J. Morgan Gordon Cook Ben Kinnersley Martin Kaiser Richard S. Houlston Source Type: research

A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis
Blood Cancer Journal, Published online: 14 October 2020; doi:10.1038/s41408-020-00368-1A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 14, 2020 Category: Hematology Authors: Alessandra Carobbio Paola Guglielmelli Elisa Rumi Chiara Cavalloni Valerio De Stefano Silvia Betti Alessandro Rambaldi Maria Chiara Finazzi Juergen Thiele Alessandro M. Vannucchi Ayalew Tefferi Tiziano Barbui Source Type: research

ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
Blood Cancer Journal, Published online: 12 October 2020; doi:10.1038/s41408-020-00364-5ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 12, 2020 Category: Hematology Authors: Yu-Hung Wang Chien-Chin Lin Sze-Hwei Lee Cheng-Hong Tsai Shan-Ju Wu Hsin-An Hou Tai-Chung Huang Yuan-Yeh Kuo Ming Yao Koping Chang Chung-Wu Lin Yun-Chu Lin Fen-Ming Tien Wen-Chien Chou Jih-Luh Tang Hwei-Fang Tien Source Type: research

CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program
Blood Cancer Journal, Published online: 06 October 2020; doi:10.1038/s41408-020-00361-8CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 5, 2020 Category: Hematology Authors: Fabio Guolo Luana Fianchi Paola Minetto Marino Clavio Michele Gottardi Sara Galimberti Giuliana Rizzuto Michela Rondoni Giambattista Bertani Michela Dargenio Atto Bilio Barbara Scappini Patrizia Zappasodi Anna Maria Scattolin Francesco Grimaldi Giuseppe P Source Type: research

Single-nucleotide variants in TGFB1, TGFBR2, IL17A, and IL17F immune response genes contribute to follicular lymphoma susceptibility and aggressiveness
Blood Cancer Journal, Published online: 06 October 2020; doi:10.1038/s41408-020-00365-4Single-nucleotide variants in TGFB1, TGFBR2, IL17A, and IL17F immune response genes contribute to follicular lymphoma susceptibility and aggressiveness (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 5, 2020 Category: Hematology Authors: Guilherme Rossi Assis-Mendon ça Gustavo Jacob Louren ço M árcia Torresan Delamain Vladmir Cl áudio Cordeiro de Lima Gisele Wally Braga Colleoni C ármino Antônio de Souza Fernando Augusto Soares Carmen Silvia Passos Lima Jos é Vassallo Source Type: research

FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome
Blood Cancer Journal, Published online: 06 October 2020; doi:10.1038/s41408-020-00362-7FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 5, 2020 Category: Hematology Authors: Michael Schieber Christian Marinaccio Lyndsey C. Bolanos Wendy D. Haffey Kenneth D. Greis Daniel T. Starczynowski John D. Crispino Source Type: research

Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myeloma
Blood Cancer Journal, Published online: 02 October 2020; doi:10.1038/s41408-020-00363-6Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 1, 2020 Category: Hematology Authors: Marcella A. Tschautscher Dragan Jevremovic Francis K. Buadi Martha Q. Lacy Morie A. Gertz Angela Dispenzieri Prashant Kapoor David Dingli Lisa Hwa Amie Fonder Miriam Hobbs Suzanne Hayman John Lust Stephen J. Russell Nelson Leung Ronald S. Go Yi Lin Wilson Source Type: research

Multiple myeloma current treatment algorithms
Blood Cancer Journal, Published online: 28 September 2020; doi:10.1038/s41408-020-00359-2Multiple myeloma current treatment algorithms (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 27, 2020 Category: Hematology Authors: S. Vincent Rajkumar Shaji Kumar Source Type: research

The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma
Blood Cancer Journal, Published online: 25 September 2020; doi:10.1038/s41408-020-00360-9The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 24, 2020 Category: Hematology Authors: Maria Gavriatopoulou Andriani Βoultadaki Vassilis Koutoulidis Ioannis Ntanasis-Stathopoulos Charis Bourgioti Panagiotis Malandrakis Despina Fotiou Magdalini Migkou Nikolaos Kanellias Evangelos Eleutherakis-Papaiakovou Efstathios Kastritis Evangelos Terpo Source Type: research

Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab
Blood Cancer Journal, Published online: 16 September 2020; doi:10.1038/s41408-020-00358-3Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 15, 2020 Category: Hematology Authors: Massimo Gentile Enrica Antonia Martino Andrea Visentin Marta Coscia Gianluigi Reda Paolo Sportoletti Francesca Romana Mauro Luca Laurenti Marzia Varettoni Roberta Murru Annalisa Chiarenza Ernesto Vigna Francesco Mendicino Eugenio Lucia Sabrina Bossio Anna Source Type: research

Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study
Blood Cancer Journal, Published online: 04 September 2020; doi:10.1038/s41408-020-00357-4Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 3, 2020 Category: Hematology Authors: Meletios A. Dimopoulos Sagar Lonial Darrell White Philippe Moreau Katja Weisel Jesus San-Miguel Ofer Shpilberg Sebastian Grosicki Ivan Špička Adam Walter-Croneck Hila Magen Maria-Victoria Mateos Andrew Belch Donna Reece Meral Beksac Andrew Spencer Heath Source Type: research

Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis
Blood Cancer Journal, Published online: 01 September 2020; doi:10.1038/s41408-020-00354-7Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 31, 2020 Category: Hematology Authors: Shayna Sarosiek Luke Zheng J. Mark Sloan Karen Quillen Dina Brauneis Vaishali Sanchorawala Source Type: research

Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms
Blood Cancer Journal, Published online: 01 September 2020; doi:10.1038/s41408-020-00356-5Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 31, 2020 Category: Hematology Authors: Matteo Giaccherini Angelica Macauda Nicola Sgherza Juan Sainz Federica Gemignani Jos è Manuel Sanchez Maldonado Manuel Jurado Francesca Tavano Grzegorz Mazur Andr és Jerez Joanna G óra-Tybor Aleksandra Go łos Francisca Hern ández Mohedo Joaquin Marti Source Type: research

Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy
Blood Cancer Journal, Published online: 01 September 2020; doi:10.1038/s41408-020-00355-6Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 31, 2020 Category: Hematology Authors: Paolo Milani Marco Basset Mario Nuvolone Francesca Benigna Lara Rodigari Francesca Lavatelli Andrea Foli Giampaolo Merlini Giovanni Palladini Source Type: research